Case series of protective ventilation for ARDS using partial extracorporeal CO2 removal

Rauch S.1, Roth H.2, Deininger T.2, Kuhwald A.2, Lund L.3, Fischer M.1 1ALB FILS KLINIKEN, Anesthesiology, Göppingen, Germany, 2ALB FILS KLINIKEN, Internal Medicine, Göppingen, Germany, 3ALung Technologies Inc., Pittsburgh, United States Poster presentation from the EuroELSO 2015 4th International Congress Objectives In the ARDS Network trial of low tidal volume ventilation, hypercapnia and respiratory acidosis (read more)

A retrospective observational case series of low flow veno-venous extracorporeal carbon dioxide removal use in patients with respiratory failure

Moss C.E., Galtrey E., Gillon S., Langrish C., Meadows C., Wyncoll D., Ioannou N., Camporota L., Tricklebank S., Daly K., Evans S., Ong D., Sanderson B., Waldie J., Dando R., Elliott-Hammond C., Lozinski M., Nichols H., Barrett N. Department of Critical Care, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom Poster presentation from the (read more)

Initial Australian Experience with the Hemolung RAS presented at EURO-ELSO

Dr. Hergen Buscher of St. Vincent’s Hospital (Sydney, Australia) recently presented the initial Australian Hemolung RAS experience at the EURO-ELSO 2014 conference in Paris. In his report, three COPD patients suffering acute exacerbations and deemed to be at a high risk of being intubated were successfully treated with the Hemolung RAS. View the Poster    (read more)

Avoidance Of Intubation For A Lung Transplant Candidate Using Extracorporeal Carbon Dioxide Removal With The Hemolung During An Acute COPD Exacerbation – A Case Report

M. Irlbeck, MD, M. Zoller, MD, T. Weig, MD, Presenting author T. Klaus, MD Department of Anaesthesiology, Hospital of the University of Munich, Munich, Germany This case report describes the use of a novel extracorporeal carbon dioxide removal (ECCO2R) device to facilitate avoidance of intubation in a lung transplant candidate experiencing an acute exacerbation of (read more)

New Alternatives for Acute Respiratory Therapy

6 February 2014 Clinical Insights, Recent News

Acute respiratory failure is not uncommon and can occur from a variety of causes to people of all ages. Chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) are just two of many reasons why a patient may experience respiratory failure and require invasive mechanical ventilation (IMV). Approximately 13.7 million people in the United States are living with COPD, and ARDS averages approximately 160,000 cases per year. While IMV has proven to be an indispensible therapy for persons undergoing such incidents, an increased understanding of further lung injury that can in fact be caused by the ventilator has led to a shift in the paradigms for providing respiratory support. A new device offers a minimally invasive option for respiratory support that may allow patients to either avoid IMV or mitigate its injurious side effects. (read more)

CEO Insights: Changing the standard of care for acute respiratory therapy

31 January 2014 Clinical Insights, Recent News

ALung chairman & CEO Peter DeComo talks about advances in respiratory therapy and his company's Hemolung respiratory system. (read more)